Research site

HUS Helsinki University Hospital

Finland Haartmaninkatu 4, 00029 Helsinki, Finland

Hormone-refractory prostate cancer · Prostate cancer metastatic
Adult patients

About Specializations

HUS Helsinki University Hospital in Helsinki, Finland specialises in clinical trials of conditions such as Hormone-refractory prostate cancer, Prostate cancer metastatic, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Haartmaninkatu 400029 HelsinkiFinland

Open in maps ↗

Recruiting now: no trials
Conditions studied: 2

More sites in Helsinki Finland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

1 clinical trial

Hormone-refractory prostate cancer+1

Not recruiting

Registered drug

Study on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:Enzalutamide
Sponsor:Pfizer Inc.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites